1. Improving Outcomes in a Recent ACS Part 1: Anticoagulation in a STEMI Patient

2. Treatment Options to Consider

4. ATOLL: IV Enoxaparin in Primary PCI:

5. ATOLL: Results

6. ESC Guidelines: Periprocedural Anticoagulant Medication in Primary PCI

7. ACCF/AHA Guidelines: Adjunctive Anticoagulant Therapy in Primary PCI

8. Rivaroxaban: ATLAS ACS 2-TIMI 51: Study Design

9. ATLAS ACS 2-TIMI 51: Mortality Benefit With Very Low-Dose Rivaroxaban in STEMI Patients

11. Otamixaban: TAO Study Design

12. Abbreviations

13. Abbreviations (cont)

14. Abbreviations (cont)

15. References

16. References (cont)

17. References (cont)

18. References (cont)